Fintel reports that on March 27, 2025, Mizuho upgraded their outlook for Chemours (NYSE:CC) from Neutral to Outperform.

Chemours (NYSE:CC – Get Free Report) was upgraded by research analysts at Mizuho from a “neutral” rating to an “outperform” rating in a research note issued on Thursday, Marketbeat ...

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal ...

A month has gone by since the last earnings report for Chemours (CC). Shares have lost about 14% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

Victory Capital Management Inc. lowered its position in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN – Free Report) ...